Nianli Sang

4.4k citations
57 papers · 3.6k indexed · h-index 32
Topics
Cancer, Hypoxia, and Metabolism (20 papers)Cancer-related Molecular Pathways (11 papers)Ubiquitin and proteasome pathways (9 papers)
Partner nations
United StatesChinaItaly

In The Last Decade

Nianli Sang

56 papers receiving 3.6k citations

Peers

Nianli Sang
Comparison fields: 5 of 120
  • Molecular Biology 2.5k
  • Cancer Research 1.5k
  • Oncology 969
  • Genetics 485
  • Cell Biology 298
Replace Michelle Barton with:
Michelle Barton United States
Maurizio Fanciulli Italy
Margaret Ashcroft United Kingdom
Werner Zwerschke Austria
Adam Ertel United States
Stéphane Pyronnet France
Marie Classon United States
Lisa Oliver France
Rhoda M. Alani United States
Nianli Sang relative to Michelle Barton United States Michelle Barton's profile →
Citations per field
00.5×1.5×
Michelle Barton · 1×
Citations per year

Countries citing papers authored by Nianli Sang

Since Specialization
Citations

This map shows the geographic impact of Nianli Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianli Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianli Sang more than expected).

Fields of papers citing papers by Nianli Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianli Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianli Sang. The network helps show where Nianli Sang may publish in the future.

Co-authorship network of co-authors of Nianli Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Nianli Sang. A scholar is included among the top collaborators of Nianli Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianli Sang. Nianli Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 52
3 31
4 26
5 2
6 35
7 94
8 33
9 62
10 53
11 73
12 50
13 219
14 70
15 12
16 301
17 25
18 7
19 15
20 278

About Nianli Sang

Nianli Sang is a scholar working on Cancer Research, Aging and Molecular Biology, having authored 57 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (20 papers), Cancer-related Molecular Pathways (11 papers) and Ubiquitin and proteasome pathways (9 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (2.5k citations) and Oncology (969 citations). Nianli Sang has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Antonio Giordano, J. Jaime, Vickram Srinivas, Shuyang Chen, Dongming Liang, Xianguo Kong, Shuo Qie, Xavier Graña, О. H. Minchenko and Daniel P. Stiehl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026